Oralair® - sublingual tablets for specific immunotherapy of grass-pollen allergy

Abstract

Sublingual tablet for specific grass-pollen allergen immunotherapy has a well documented efficacy and safety in children, adolescents and adults. Indication of this vaccine responds highly to other allergen vaccines.

Keywords

• sublingual immunotherapy
• allergic rhinitis
• grass-pollen allergy